medigraphic.com
Colegio de Medicina Interna de México.

2007, Number 5

<< Back Next >>

Med Int Mex 2007; 23 (5)

Intestinal amibiais: current state of its knowledge

Ximénez C, Morán P, Ramos F, Ramiro M

Language: Spanish
References: 66
Page: 398-407
PDF size: 158.79 Kb.


ABSTRACT

Diarrhoea illness keep on being an important problem of public health, with a high load of morbidity and even mortality for his complications. The protozoar parasite Entamoeba hystolitica is the causal agent of the amibiasis. His coprologyc diagnosis performs big importance, just as his appropriate treatment, elements that constitute the intention of this updated review of the current state of the amibiasis, specially of his biological behavior, morbidity and mort


REFERENCES

  1. World Health Organization. Amoebiasis. Wkly Epidemiol Rec 1997;72:97-100.

  2. Martínez-Palomo A. Parasitic Amebas of the intestinal tract. In: Parasitic Protozoa. Kreiev JP, Baker JR (editors). 2th ed. New York: Academic Press, 1993;pp:65-141.

  3. Clark CG. Amoebic disease. Entamoeba dispar, an organism reborn. Trans R Soc Trop Med Hyg 1998;92:361-64.

  4. Martínez-Palomo A, González-Robles A, De la Torre M. Selective agglutination of pathogenic strains of Entamoeba histolytica induced by ConA. Nature New Biology 1973;245:186-7.

  5. Sargeaunt PG, Williams JE, Grene JD. The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis. Trans R Soc Trop Med Hyg 1978;72:519-21.

  6. Strachan WD, Chiodini PL, Spice WM, Moody AH, Ackers JP. Immunological differentiation of pathogenic and non-pathogenic isolates of Entameoba histolytica. Lancet 1988;1:561-3.

  7. Clark CG, Diamond LS. Ribosomal RNA genes of pathogenic and nonpathogenic Entamoeba histolytica are distinct. Mol Biochem Parasitol 1991;49:297-302.

  8. Tannich E, Horstmann RD, Knobloch J, Arnold HH. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci USA 1989;86:5118-22.

  9. Diamond LS, Clark CG. A redescription of Entamoeba histolytica Schaudinn, 1903. (Emended Walter, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Euk Microbiol 1993;40:340-4.

  10. Mai Z, Ghosh S, Frisardi M, Rosenthal B, Rogers R, Samuelson J. Hsp60 is targeted to a cryptic mitochondrion derived organelle (crypton) in the microaerophilic protozoan parasite Entamoeba histolytica. Mol Cell Biol 1999; 19:2198-205.

  11. Vago AR, Andrade LO, Leite AA, Reis D, Macedo AM, Adad SJ, et al. Genetic characterization of Trypanosoma cruzi direcly from tissues of patients with chronic Chagas disease. Am J Pathol 2000;156:1805-9.

  12. Bapteste E, Brinkman H, Lee JA, Moore DV, Sensen CW, Gordon P, et al. The analysis of 100 genes supports the grouping of three highly divergent amoebae: Dictyostelium, Entamoeba and Matigamoeba. Proc Natl Ac Sci USA 2002; 99:1414-19.

  13. Clark CG. The evolution of Entamoeba, a cautionary tale. Res Micrbiol 2000;151: 599-603.

  14. Willhoeft U, Tannich E. The electrophoretic karyotype of Entamoeba histolytica. Mol Biochem Parasitol 1999;99:41-53.

  15. Lofftus B, Anderson I, Davies R, Alsmark UC, Samuelson J, Amedeo P, et al. The genome of the protist parasite Entamoeba histolytica. Nature 2005;433: 865-88.

  16. Davis PH, Schulze J, Stanley SL. Transcriptonic comparison of two Entamoeba histolytica strains with defined virulence phenotypes identifies new virulence factor candidates and key differences in the expression patterns of cystein proteases, lectin light chains, and calmodulin. Mol Biochem Parasitol 2007;151: 118-28.

  17. Tolstrup J, Krause E, Tannich E, Bruchhaus I. Proteomic analysis of Entamoeba. Parasitol Res 2006;134:289-98.

  18. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986;8:228-38.

  19. Cabellero-Salcedo A, Viveron-Rogel M, Salvatierra B, Tapia- Conyer R, Sepúlveda-Amor J, Gutierrez G, Ortíz-Ortíz L. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg 1994;50:412-19.

  20. Secretaria de Salud. Epidemiología. Información epidemiológica de morbilidad. Secretaria de Salud, México DF, 2000;pp:15-32.

  21. Ximénez C. Parasitosis intestinales en México. Cuadernos FunSalud (34). México: Fundación Mexicana para la Salud, 2000.

  22. Evangelopoulos A, Spanakos G, Patsoula, Vakalis N. A nested, multiplex PCR assay for the simultaneous detection and differentiation of Entamoeba histolytica and Entamoeba dispar in feces. Ann Trop Med Parasitol 2000;94:233-40.

  23. Ramos F, García G, Valadez A, Morán P, González E, Gómez A, Melendro EI, Ximénez C. E. dispar: Analysis of polymorphism as a tool for study of geographic distribution. Mol Biochem Parasitol 2005;141:175-77.

  24. Ximénez C. Epidemiology of Amebiasis in México: A molecular approach. Arch Med Res 2006;37:263-65.

  25. Valenzuela O, Morán P, Gomez A, Cordoba K, Corrales N, Cardoza J, Gomez R, Cano M, and Ximénez C. Epidemiology of amebic liver abscess in México: the case of Sonora. Am J Trop Med Hyg 2007 (en prensa).

  26. Acuña-Soto R, Samuelson J, Girolami P, Zarate L, Millan- Velasco F, Schoolnick G, Wirth D. Application of the polymerase chain reaction to the epidemiology of pathogenic and nonpathogenic Entamoeba histolytica. Am J Trop Med Hyg 1993;48:58-70.

  27. Newton-Sanchez O, Sturm-Ramirez K, Romero-Zamora JL, Santos-Preciado JI, Samuelson J. High rate of occult infection with Entamoeba histolytica among non-dysenteric mexican children. Arch Med Res 1997;28 suppl:311-13.

  28. Ramos F, Morán P, González E, García G, Ramiro M, Gómez A, et al. High prevalence rate of E. histolytica asymptomatic infection in a rural Mexican community. Am J Trop Med Hyg 2005;73(1):89-91.

  29. De la Vega H, Specht CA, Semino CE, Robbins PW, Eichinger D, Caplivski D, et al. Cloning and expression of chitinases of Entamoeba. Mol Biochem Parasitol 1997;85:139-47.

  30. Stanley SL, Becker A, Kunz-Jenkins C, Foster L, Li E. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proc Natl Acad Sci 1990;87: 4976-80.

  31. Burch DJ, Li E, Reed S, Jackson TFHG, Stanley SL. Isolation of a strain-specific Entamoeba histolytica cDNA clone. J Clin Microbiol 1991;29:696-701.

  32. Clark CG, Diamond LS. Entamoeba histolytica: a method for isolate identification. Exp Parasitol 1993;77: 450-55.

  33. Ghosh S, Frisardi M, Ramirez-Avila L, Descoteaux S, Sturm- Ramirez K, Newton-Sanchez AO, et al. Molecular epidemiology of Entamoeba spp: evidence of a bottleneck (Demographic sweep) and transcontinental spread of diploid parasites. J Clin Microbiol 2000;38:3815-21.

  34. Clark CG, Ali IKM, Kaki M, Loftus BJ, Hall N. Unique organization of tRNA genes in Entamoeba histolytica. Mol Biochem Parasitol 2006;146:24-29.

  35. Ayeh-Kumi PF, Ali IM, Lockhart LA, Gilchrist CA, Petri WA, Haque R. Entamoeba histolytica: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich protein gene. Exp Parasitol 2001;99:80-88.

  36. Ali IKM, Mondal U, Roy S, Haque R, Petri WA, Clark CG. Evidence for the link between parasite genotype and outcome of infection with Entamoeba histolytica. J Clin Microbiol 2007;45:285-9.

  37. Haque R, Neville LM, Hahn P, Petry WA. Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection Kits. J Clin Microbiol 1995;33:2558-61.

  38. Frederick JR, Petri WA Jr. Roles for the galactose/N-acetylgalactosamine binding lectin of Entamoeba in parasite virulence and differentiation. Glycobiology 20005;15:53R-59R.

  39. Petri WA Jr. Pathogenesis of amebiasis. Curr Opin Microbiol 2002;5:443-7.

  40. Cuervo P, Cupolillo E, Nehme N, Hernández V, Saravia N, Fernandes O. Leishmania (Viannia): genetic analysis of cutaneous and mucosal strains isolated from the same patient. Exp Parasitol 2004;108:59-66.

  41. Kebede A, Verweij J, Dorigo-Zetsman W, Sanders E, Messele T, Van Lieshou, et al. Overdiagnosis of amoebiasis in the absence of Entamoeba histolytica among patients presenting with diarrhoea in Wonji and Akaki, Ethiopia. Trans R Soc Trop Med Hyg 2003;97:305-7.

  42. Leippe M, Bruhn H, Hecht O, Grotzinger J. Ancient weapons: the three-dimensional structure of amoebopore A. Trends Parasitol 2005;21:5-7.

  43. Ackers J, Mirelman D. Progress in research on Entamoeba histolytica pathogenesis. Curr Opin Microbiol 2006;9:367-73.

  44. Jaramillo-Luna R, Campos RR, Tsutsumi V. Participation of neutrophils, macrophages, and endothelial cells in the amebic liver lesion in the mouse. Arch Med Res 2000;31:S231-S233.

  45. Tsutsumi V, Mena LR, Anaya VF, Martínez-Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol 1984;117:81-91.

  46. Seguin R, Mann BJ, Keller K, Chadee K. The tumor necrosis factor alpha-stimulating region of galactose inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide Infect Immun 1997;65:2522-27.

  47. Campbell D, Mann BJ, Chadee K. A subunit vaccine candidate region of the Entamoeba histolytica galactose-adherence lectin promotes interleukin-12 gene transcription and protein production in human macrophages. Eur J Immunol 2000;30:423-30.

  48. Que X, Reed SL. Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 2000;13:196-206.

  49. MacFarlane RC, Singh U. Identification of differentially expressed genes in virulent and non virulent Entamoeba species: potential implication for amebic pathogenesis. Infect Immun 2006;74:340-51.

  50. Pérez-Rodríguez M, Arellano J, López-Osuna M, Velásquez J, Granados J, Justiniani N, et al. Increased frequency of HLA-DR3 and complotype SC01 in Mexican mestizo children with amebic abscess of the liver and summary of our overall HLA-SCO1 experience in invasive amebiasis. Arch Med Res 1997;28 suppl:S245-S247.

  51. Duggal P, Haque R, Roy S, Mondal D, Sack RB, Farr BM, et al. Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. J Infect Dis 2004;189:520-6.

  52. Padilla-Vaca F, Ankri S, Bracha R, Koole LA, Mirelman D. Down regulation of Entamoeba histolytica virulence by monoxenic cultivation with Escherichia coli 055 is related to a decrease in expression of the light (35-kilodaltons) subunit of the Gal/ Ga1NAc lectin. Infect Immun 1999;65:2096-102.

  53. Haque R, Duggal P, Ali IM, Hossain MB, Mondal D, Sack RB, et al. Innate and acquired resistance to amebiasis in Bangladeshi children, J Infect Dis 2002;186: 547-52.

  54. Salata RA, Martínez-Palomo A, Murray HW, Conales L, Treviño N, Segovia E, et al. Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica J Immunol 1986; 136:2633-39.

  55. Campell D, Chadee K. Interleukin (IL)2, IL-4 and tumor necrosis factor-alpha responses during Entamoeba histolytica liver abscess development in gerbils. J Infect Dis 1997;175:1176-83.

  56. Seydel KB, Smith SJ, Stanley SL, Jr. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model disease. Infect Immun 2000;68:400-2.

  57. Ivory CP, Chadee K. Activation of dendritic cells by the Gallectin of Entamoeba histolytica drives Th-1 responses in vitro and in vivo. Eur J Immunol 2007;37:385-94.

  58. Banchereau J, Briere F, Caux C, Dovoust J, Lebecque S, Liu YD, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.

  59. Blessman J, Van Linh P, Nee PA, Thi HD, Mueller MB, Buss H, Tannich E. Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam. Am J Trop Med Hyg 2002;66:578-83.

  60. De Alencar LC, Magalhaes V de Melo VM, Ska I, Magalhaes M, Kobayashi S. The absence of invasive amebiasis in male homosexual AIDS patients in Recife. Rev Soc Bros Med Trop 1996;29:319-22.

  61. Morán P, Ramos F, Ramiro M, Curiel O, González E, Valadez A, et al. Infection by human immunodeficiency virus 1 is not a risk factor for amebiasis. Am J Trop Med Hyg 2005;73:296-300.

  62. Haque R, Mollah NU, Ali IK, Alam K, Eubanks A, Lyerly D, Petri WA Jr. Diagnosis of amebic liver abscess and intestinal infection with the Tech Lab Entamoeba histolytica II antigen detection and antibody test. J Clin Microbiol 2000;38:3235-39.

  63. Treviño GMN, Escandon RC, Cabral SJ, Escobedo de la PJ, Olvera AJ, Silva BA. Patterns of the morbidity and mortality of amoebiasis and amebic liver abscess in Mexico: and ecological analysis. Arch Med Res 1997;28:290-2.

  64. Grimes DA, Shulz KF. Refining chemical diagnosis with likelihood ratios. Lancent 2005;365:1500-5.

  65. Chebolu S, Daniell H. Stable expression of Gal/Gal NAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnol J 2007;5:230-39.

  66. Stanley SL Jr. Vaccines for amoebiasis: barriers and opportunities. Parasitology 2006;133 suppl:S81-S86.




2020     |     www.medigraphic.com